Study of Two Malaria Vaccines
Author Information
Author(s): Malkin Elissa, Long Carole A, Stowers Anthony W, Zou Lanling, Singh Sanjay, MacDonald Nicholas J, Narum David L, Miles Aaron P, Orcutt Andrew C, Muratova Olga, Moretz Samuel E, Zhou Hong, Diouf Ababacar, Fay Michael, Tierney Eveline, Leese Philip, Mahanty Siddhartha, Miller Louis H, Saul Allan, Martin Laura B
Primary Institution: Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Hypothesis
The study aims to assess the safety and immunogenicity of two vaccines targeting Plasmodium falciparum malaria.
Conclusion
The MSP142/Alhydrogel vaccines were safe and well tolerated but not sufficiently immunogenic to generate a biologic effect in vitro.
Supporting Evidence
- 74% of volunteers receiving MSP142-FVO/Alhydrogel developed antibodies.
- 81% of volunteers receiving MSP142-3D7/Alhydrogel developed antibodies.
- Antibodies were cross-reactive to both MSP142-FVO and MSP142-3D7 proteins.
- Minimal in vitro growth inhibition of malaria parasites was observed.
- Pain at the injection site was the most common side effect.
- Majority of side effects were mild.
- No serious adverse events were attributed to the vaccines.
Takeaway
The study tested two malaria vaccines on healthy volunteers and found they were safe but didn't work well enough to fight the disease.
Methodology
A Phase 1 open-label, dose-escalating study with 60 healthy volunteers receiving two different vaccines at three dose levels.
Potential Biases
The alternation method for assigning individuals to vaccines may introduce bias.
Limitations
The small number of participants and lack of a placebo arm limit the ability to detect differences in side effects.
Participant Demographics
60 healthy malaria-naïve volunteers aged 18-48, including 26 males and 34 females.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% confidence interval: -19 to 13
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website